Skin cancer
According to the World Health Organisation both non-melanoma and melanoma skin cancers have been increasing over the past decades; we are now facing an epidemic of these conditions. How did we get to this stage? Various initiatives including the ABCDE of melanoma have been developed by prestigious institutions to improve awareness and diagnosis but there is still no improvement in the prevalence of melanoma. Why is prevention apparently not effective and how hopeful does the future look? In this section we are aiming to provide a skin cancer focus in our daily bibliography coverage.
#ASCO16 news about metastatic #melanoma #skincancer
The Evolving Treatment Landscape of Metastatic #Melanoma: From Ipilimumab to New Checkpoint Inhibitors https://t.co/yypM2sZmUP #ASCO16
— ASCO (@ASCO) June 4, 2016
#ASCO16 news about metastatic #melanoma #skincancer
Examining the role of combination #immunotherapy treatment for patients w/ metastatic melanoma https://t.co/K4HkHD8tEj #ASCO16
— ASCO (@ASCO) June 4, 2016
RT @PoschChristian: ASCO – the Woodstock of oncology. #ASCO16 #cancer #melanoma #pd1 pic.twitter.com/dYtLBKDn0h
About #asco16 Educational Book. Among others #melanoma #skincancer
Over 250 oncologists and researchers contributed to the #ASCO16 Educational Book. Have you read it yet? https://t.co/aKanDBqqsc
— ASCO (@ASCO) June 5, 2016
RT @wtspres: Helpful pictures but doesn’t replace experienced dermatologist #asco16 #skincancer #melanoma
Online Tool Helps Users Distinguish Moles from #Melanoma https://t.co/UqVfGiszEM @NCIEpiTraining #SkinCancer #ASCO16 pic.twitter.com/jv8KI4ktd7
— National Cancer Inst (@theNCI) June 4, 2016
Does sunscreen really protect my skin? Your paranoid sunscreen questions answered @voxdotcom vox.com/2016/6/3/11831… #sunscreens #skincancer
Eventual cancer “cure” #skincancer #asco16
Promising drugs stoke talk of eventual cancer 'cure' https://t.co/hPzcZboHTl
— Reuters Health (@Reuters_Health) June 3, 2016
RT @JSD_PiscoMed: RT: “Sunscreen” Gene May Guard Against #Melanoma
genengnews.com/gen-news-highl… via @GENbio
#Dermatology #skincancer
#ASCO16 and #skincancer #cancerawareness
Skin cancer: pembrolizumab gives '40% melanoma survival' #ImmunoOnc #ASCO16 https://t.co/Z1B6F4wfB8
— Miguel Perales M.D. (@DrMiguelPerales) May 19, 2016
#ASCO16 and #skincancer #cancerawareness
Read the #Keytruda #pembrolizumab #ASCO16 results now on #medipaper #ImmuneCheckPoint #melanoma #nsclc #skincancerhttps://t.co/zvU3tthBPP
— MEDIPAPER | 醫學作家香港 (@MediPaper) May 20, 2016
